Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/20/2024 | $7.50 → $7.00 | Equal Weight → Underweight | Wells Fargo |
| 7/19/2024 | Neutral | BTIG Research | |
| 3/4/2024 | $11.00 → $7.00 | Buy → Underperform | BofA Securities |
| 12/6/2023 | $10.50 | Neutral | UBS |
| 12/5/2023 | Mkt Outperform → Mkt Perform | JMP Securities | |
| 9/13/2023 | $10.00 | Equal Weight | Wells Fargo |
| 8/18/2023 | Outperform → Mkt Perform | Raymond James | |
| 4/25/2023 | Buy → Neutral | BTIG Research |
Fourth quarter GAAP net income (loss) of $(10.7) million or $(0.20) per diluted common share and Distributable Earnings (Loss)(1) of $(8.3) million or $(0.15) per diluted common share Full year GAAP net income (loss) of $(35.0) million or $(0.64) per diluted common share and Distributable Earnings (Loss)(1) of $(44.6) million or $(0.82) per diluted common share - Subsequent to the year ended December 31, 2024 - Declared first quarter 2025 dividend of $0.15 per common share Collected $166 million in repayments resulting in available capital of over $200 million(2) Ares Commercial Real Estate Corporation (the "Company") (NYSE:ACRE), a specialty finance company primarily engaged in d
Ares Commercial Real Estate Corporation (NYSE:ACRE) announced today that it will report earnings for the fourth quarter and full year ended December 31, 2024 on Wednesday, February 12, 2025 prior to the opening of the New York Stock Exchange. Ares Commercial Real Estate Corporation will hold its webcast/conference call on the same day at 11:00 a.m. Eastern Time to discuss its fourth quarter and full year ended December 31, 2024 financial results. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Home page of the Investor Resources section of our website at http://www.arescre.com. Please visit the webs
Ares Commercial Real Estate Corporation (NYSE:ACRE) (the "Company") today announced the 2024 tax treatment for the Company's common stock distributions (CUSIP # 04013V-10-8). Form 1099 Reference: Box 1a Box 1b Box 2a Box 3 Box 5 Record Date Payment Date Cash Distribution Per Share Allocable to 2024 Total Ordinary Dividends Qualified Dividends (1) Total Capital Gain Distributions Nondividend Distributions Section 199A Dividends (1) 12/29/2023 1/17/2024 $0.3300(2) $0.0000 $0.0000 $0.0000 $0.0000
Wells Fargo downgraded Ares Commercial Real Estate from Equal Weight to Underweight and set a new price target of $7.00 from $7.50 previously
BTIG Research resumed coverage of Ares Commercial Real Estate with a rating of Neutral
BofA Securities downgraded Ares Commercial Real Estate from Buy to Underperform and set a new price target of $7.00 from $11.00 previously
4 - Ares Commercial Real Estate Corp (0001529377) (Issuer)
4 - Ares Commercial Real Estate Corp (0001529377) (Issuer)
4 - Ares Commercial Real Estate Corp (0001529377) (Issuer)
4 - Ares Commercial Real Estate Corp (0001529377) (Issuer)
DEFA14A - Ares Commercial Real Estate Corp (0001529377) (Filer)
DEF 14A - Ares Commercial Real Estate Corp (0001529377) (Filer)
8-K - Ares Commercial Real Estate Corp (0001529377) (Filer)
Ares Commercial Real Estate Corporation announced today that it has appointed Rebecca Parekh to its Board of Directors, effective immediately. Ms. Parekh's appointment expands the Board from seven to eight members, including six independent board members. Ms. Parekh is the Co-Founder and Chief Executive Officer of The Well, a series of wellness facilities. Previously, she served as the Chief Operating Officer for Deepak Chopra Radical Well-Being, LLC. Prior to that, Ms. Parekh spent ten years at Deutsche Bank Securities, Inc., focused primarily on structured credit where she held various positions, including Head of the U.S. Private Institutional Client Group and Head of Cross Product Sale
Fourth quarter GAAP net income (loss) of $(10.7) million or $(0.20) per diluted common share and Distributable Earnings (Loss)(1) of $(8.3) million or $(0.15) per diluted common share Full year GAAP net income (loss) of $(35.0) million or $(0.64) per diluted common share and Distributable Earnings (Loss)(1) of $(44.6) million or $(0.82) per diluted common share - Subsequent to the year ended December 31, 2024 - Declared first quarter 2025 dividend of $0.15 per common share Collected $166 million in repayments resulting in available capital of over $200 million(2) Ares Commercial Real Estate Corporation (the "Company") (NYSE:ACRE), a specialty finance company primarily engaged in d
Ares Commercial Real Estate Corporation (NYSE:ACRE) announced today that it will report earnings for the fourth quarter and full year ended December 31, 2024 on Wednesday, February 12, 2025 prior to the opening of the New York Stock Exchange. Ares Commercial Real Estate Corporation will hold its webcast/conference call on the same day at 11:00 a.m. Eastern Time to discuss its fourth quarter and full year ended December 31, 2024 financial results. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Home page of the Investor Resources section of our website at http://www.arescre.com. Please visit the webs
Ares Commercial Real Estate Corporation (NYSE:ACRE) (the "Company") today announced the 2024 tax treatment for the Company's common stock distributions (CUSIP # 04013V-10-8). Form 1099 Reference: Box 1a Box 1b Box 2a Box 3 Box 5 Record Date Payment Date Cash Distribution Per Share Allocable to 2024 Total Ordinary Dividends Qualified Dividends (1) Total Capital Gain Distributions Nondividend Distributions Section 199A Dividends (1) 12/29/2023 1/17/2024 $0.3300(2) $0.0000 $0.0000 $0.0000 $0.0000
SC 13G/A - Ares Commercial Real Estate Corp (0001529377) (Subject)
SC 13G/A - Ares Commercial Real Estate Corp (0001529377) (Subject)
SC 13G - Ares Commercial Real Estate Corp (0001529377) (Subject)